Cumberland Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.36M Buy
+3,500
New +$1.36M 0.09% 122
2024
Q4
Sell
-19,396
Closed -$10.1M 178
2024
Q3
$10.1M Buy
19,396
+155
+0.8% +$80.6K 0.7% 34
2024
Q2
$10.4M Buy
19,241
+634
+3% +$344K 0.76% 33
2024
Q1
$9.65M Sell
18,607
-10,867
-37% -$5.63M 0.7% 33
2023
Q4
$13M Sell
29,474
-406
-1% -$179K 1.19% 24
2023
Q3
$13M Sell
29,880
-189
-0.6% -$82.3K 1.25% 24
2023
Q2
$13.4M Sell
30,069
-217
-0.7% -$96.4K 1.23% 24
2023
Q1
$13.9M Sell
30,286
-5,320
-15% -$2.45M 1.37% 25
2022
Q4
$18.3M Buy
35,606
+15,154
+74% +$7.77M 1.92% 19
2022
Q3
$9.29M Buy
20,452
+370
+2% +$168K 0.99% 31
2022
Q2
$9.69M Buy
20,082
+8,232
+69% +$3.97M 0.92% 31
2022
Q1
$5.82M Sell
11,850
-366
-3% -$180K 0.44% 53
2021
Q4
$5.66M Sell
12,216
-1
-0% -$464 0.4% 63
2021
Q3
$4.55M Buy
12,217
+422
+4% +$157K 0.37% 72
2021
Q2
$4.5M Sell
11,795
-966
-8% -$369K 0.35% 74
2021
Q1
$4.58M Buy
12,761
+933
+8% +$335K 0.38% 70
2020
Q4
$3.8M Buy
11,828
+1,363
+13% +$438K 0.34% 72
2020
Q3
$2.81M Buy
10,465
+1,906
+22% +$512K 0.29% 74
2020
Q2
$2.25M Buy
8,559
+5,709
+200% +$1.5M 0.23% 82
2020
Q1
$647K Sell
2,850
-1,175
-29% -$267K 0.08% 118
2019
Q4
$1.22M Buy
4,025
+775
+24% +$234K 0.11% 106
2019
Q3
$780K Buy
3,250
+1,500
+86% +$360K 0.08% 112
2019
Q2
$494K Buy
+1,750
New +$494K 0.05% 138
2019
Q1
Sell
-4,700
Closed -$1.23M 168
2018
Q4
$1.23M Buy
+4,700
New +$1.23M 0.14% 92